Kyla Driscoll is currently the Head of Discovery Strategy and Scientific Operations in Oncology at Eli Lilly and serves as the Site Head for Lilly NYC. Previously, Kyla held various roles at Eli Lilly including Research Fellow, Senior Research Advisor, and Principal Scientist, specializing in immuno-oncology. In 2023, Kyla briefly served as the Head of Large Molecule Biology and Discovery Technologies at Loxo@Lilly and was the Chief Scientific Officer for Immuno-Oncology. Kyla is pursuing a Bachelor of Arts at Drew University and a PhD in Microbiology and Immunology at Rutgers University.
This person is not in any teams
This person is not in any offices